相似文献
1
The marketing of a disease: female sexual dysfunction.
BMJ. 2005 Jan 22;330(7484):192-4. doi: 10.1136/bmj.330.7484.192.
2
Resurgence of interest in sexual dysfunction?
BJU Int. 2012 Jun;109(11):E36-7. doi: 10.1111/j.1464-410X.2012.11249.x.
3
The hunt for pink Viagra.
BJU Int. 2005 Jan;95(1):181-2. doi: 10.1111/j.1464-410X.2005.05273.x.
4
The female sexual dysfunction (FSD) revolution reverts to evolution.
BJU Int. 2007 Sep;100(3):697-8. doi: 10.1111/j.1464-410X.2007.07153.x.
5
Medical solutions have improved the treatment of sexological problems and created more demand for sexological care.
J Sex Marital Ther. 2007 Oct-Dec;33(5):433-7. doi: 10.1080/00926230701477154.
6
Drug maker urges group to lobby FDA on testosterone for women.
BMJ. 2004 Nov 27;329(7477):1255. doi: 10.1136/bmj.329.7477.1255.
7
Dealing in drugs.
Lancet. 2004;364(9446):1655-6. doi: 10.1016/S0140-6736(04)17375-3.
8
Intrinsa fails to impress FDA advisory panel.
Int J Impot Res. 2005 May-Jun;17(3):283-4. doi: 10.1038/sj.ijir.3901308.
9
Doctors and drug companies.
N Engl J Med. 2005 Feb 17;352(7):733-4; author reply 733-4. doi: 10.1056/NEJM200502173520722.
10
Green shoots: but will the sap rise?
BJU Int. 2010 Jan;105(1):129-30. doi: 10.1111/j.1464-410X.2009.09114.x.
引用本文的文献
1
How to Draw the Line Between Health and Disease? Start with Suffering.
Health Care Anal. 2021 Jun;29(2):127-143. doi: 10.1007/s10728-021-00434-0. Epub 2021 Apr 29.
2
Professional Conferences, Unprofessional Conduct.
Med J Armed Forces India. 2011 Jan;67(1):2-6. doi: 10.1016/S0377-1237(11)80002-X. Epub 2011 Jul 21.
3
A biopsychosocial approach to women's sexual function and dysfunction at midlife: A narrative review.
Maturitas. 2016 May;87:49-60. doi: 10.1016/j.maturitas.2016.02.009. Epub 2016 Feb 21.
4
Challenges in sexual medicine.
Nat Rev Urol. 2012 Sep;9(9):537-42. doi: 10.1038/nrurol.2012.134. Epub 2012 Jul 10.
5
Female sexual dysfunction: a case study of disease mongering and activist resistance.
PLoS Med. 2006 Apr;3(4):e178. doi: 10.1371/journal.pmed.0030178. Epub 2006 Apr 11.
6
Benefits and harms of direct to consumer advertising: a systematic review.
Qual Saf Health Care. 2005 Aug;14(4):246-50. doi: 10.1136/qshc.2004.012781.
本文引用的文献
1
Revised definitions of women's sexual dysfunction.
J Sex Med. 2004 Jul;1(1):40-8. doi: 10.1111/j.1743-6109.2004.10107.x.
2
FDA panel rejects testosterone patch for women on safety grounds.
BMJ. 2004 Dec 11;329(7479):1363. doi: 10.1136/bmj.329.7479.1363.
3
Sex in Australia: sexual difficulties in a representative sample of adults.
Aust N Z J Public Health. 2003;27(2):164-70. doi: 10.1111/j.1467-842x.2003.tb00804.x.
4
Distress about sex: a national survey of women in heterosexual relationships.
Arch Sex Behav. 2003 Jun;32(3):193-208. doi: 10.1023/a:1023420431760.
5
The making of a disease: female sexual dysfunction.
BMJ. 2003 Jan 4;326(7379):45-7. doi: 10.1136/bmj.326.7379.45.
6
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.
JAMA. 2002 Jul 17;288(3):321-33. doi: 10.1001/jama.288.3.321.
7
Selling sickness: the pharmaceutical industry and disease mongering.
BMJ. 2002 Apr 13;324(7342):886-91. doi: 10.1136/bmj.324.7342.886.
Zotero 插件